The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Denis E. O'Donnell

Department of Medicine

Queen's University

Kingston

Ontario

Canada

[email]@*.queensu.ca

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Department of Medicine, Queen's University, Kingston, Ontario, Canada. 1998 - 2007
  • Respiratory Investigation Unit, Departments of Medicine, and Community Health and Epidemiology, Queen's University, Canada. 1998 - 2006
  • Department of Medicine, Division of Respiratory and Critical Care Medicine, Queen's University, Kingston, Canada. 2001 - 2006
  • Queen's University, Kingston, Ontario. 2004 - 2006
  • 102 Stuart Street, Kingston, Ontario, Canada. 2005

References

  1. Pathophysiology of dyspnea in chronic obstructive pulmonary disease: a roundtable. O'Donnell, D.E., Banzett, R.B., Carrieri-Kohlman, V., Casaburi, R., Davenport, P.W., Gandevia, S.C., Gelb, A.F., Mahler, D.A., Webb, K.A. Proc. Am. Thorac. Soc (2007) [Pubmed]
  2. COPD exacerbations . 3: Pathophysiology. O'Donnell, D.E., Parker, C.M. Thorax (2006) [Pubmed]
  3. Hyperinflation, dyspnea, and exercise intolerance in chronic obstructive pulmonary disease. O'Donnell, D.E. Proc. Am. Thorac. Soc (2006) [Pubmed]
  4. Sensory-mechanical relationships during high-intensity, constant-work-rate exercise in COPD. O'Donnell, D.E., Hamilton, A.L., Webb, K.A. J. Appl. Physiol. (2006) [Pubmed]
  5. Effect of fluticasone propionate/salmeterol on lung hyperinflation and exercise endurance in COPD. O'Donnell, D.E., Sciurba, F., Celli, B., Mahler, D.A., Webb, K.A., Kalberg, C.J., Knobil, K. Chest (2006) [Pubmed]
  6. The clinical importance of dynamic lung hyperinflation in COPD. O'Donnell, D.E., Laveneziana, P. COPD (2006) [Pubmed]
  7. Physiological changes during symptom recovery from moderate exacerbations of COPD. Parker, C.M., Voduc, N., Aaron, S.D., Webb, K.A., O'Donnell, D.E. Eur. Respir. J. (2005) [Pubmed]
  8. What is unique about the new Canadian COPD guidelines?. O'Donnell, D.E. Can. Respir. J. (2004) [Pubmed]
  9. Effects of tiotropium on lung hyperinflation, dyspnoea and exercise tolerance in COPD. O'Donnell, D.E., Flüge, T., Gerken, F., Hamilton, A., Webb, K., Aguilaniu, B., Make, B., Magnussen, H. Eur. Respir. J. (2004) [Pubmed]
  10. Effect of salmeterol on the ventilatory response to exercise in chronic obstructive pulmonary disease. O'Donnell, D.E., Voduc, N., Fitzpatrick, M., Webb, K.A. Eur. Respir. J. (2004) [Pubmed]
  11. State of the Art Compendium: Canadian Thoracic Society recommendations for the management of chronic obstructive pulmonary disease. O'Donnell, D.E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., Maltais, F., Road, J., McKay, V., Schenkel, J., Ariel, A., Day, A., Lacasse, Y., Levy, R., Lien, D., Miller, J., Rocker, G., Sinuff, T., Stewart, P., Voduc, N., Abboud, R., Ariel, A., Becklake, M., Borycki, E., Brooks, D., Bryan, S., Calcutt, L., Chapman, K., Choudry, N., Couet, A., Coyle, S., Craig, A., Crawford, I., Dean, M., Grossman, R., Haffner, J., Heyland, D., Hogg, D., Holroyde, M., Kaplan, A., Kayser, J., Lein, D., Lowry, J., McDonald, L., MacFarlane, A., McIvor, A., Rea, J., Reid, D., Rouleau, M., Samis, L., Sin, D., Vandemheen, K., Wedzicha, J.A., Weiss, K. Can. Respir. J. (2004) [Pubmed]
  12. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease--2003. O'Donnell, D.E., Aaron, S., Bourbeau, J., Hernandez, P., Marciniuk, D., Balter, M., Ford, G., Gervais, A., Goldstein, R., Hodder, R., Maltais, F., Road, J. Can. Respir. J. (2003) [Pubmed]
  13. Exercise hypercapnia in advanced chronic obstructive pulmonary disease: the role of lung hyperinflation. O'Donnell, D.E., D'Arsigny, C., Fitzpatrick, M., Webb, K.A. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  14. Effects of hyperoxia on ventilatory limitation during exercise in advanced chronic obstructive pulmonary disease. O'Donnell, D.E., D'Arsigny, C., Webb, K.A. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  15. Ventilatory limitations in chronic obstructive pulmonary disease. O'Donnell, D.E. Med. Sci. Sports. Exerc (2001) [Pubmed]
  16. Dynamic hyperinflation and exercise intolerance in chronic obstructive pulmonary disease. O'Donnell, D.E., Revill, S.M., Webb, K.A. Am. J. Respir. Crit. Care Med. (2001) [Pubmed]
  17. Assessment of bronchodilator efficacy in symptomatic COPD: is spirometry useful?. O'Donnell, D.E. Chest (2000) [Pubmed]
  18. Respiratory sensation during chest wall restriction and dead space loading in exercising men. O'Donnell, D.E., Hong, H.H., Webb, K.A. J. Appl. Physiol. (2000) [Pubmed]
  19. Spirometric correlates of improvement in exercise performance after anticholinergic therapy in chronic obstructive pulmonary disease. O'Donnell, D.E., Lam, M., Webb, K.A. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  20. Dyspnea in advanced chronic obstructive pulmonary disease. O'Donnell, D.E. J. Heart Lung Transplant. (1998) [Pubmed]
  21. Measurement of symptoms, lung hyperinflation, and endurance during exercise in chronic obstructive pulmonary disease. O'Donnell, D.E., Lam, M., Webb, K.A. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
 
WikiGenes - Universities